disoproxil造句
例句与造句
- Discontinuation of tenofovir disoproxil can potentially lead to reversal of renal impairment.
- Long term use of tenofovir disoproxil is associated with nephrotoxicity and bone loss.
- Tenofovir Alafenamide differs from tenofovir disoproxil due to its activation in the lymphoid cells.
- Tenofovir disoproxil contains a very similar prodrug group.
- A medicinal chemistry team at Gilead developed a modified version of tenofovir, tenofovir disoproxil.
- It's difficult to find disoproxil in a sentence. 用disoproxil造句挺难的
- Nephrotoxicity may be due to proximal tubules accumulation of Tenofovir disoproxil leading to elevated serum concentrations.
- One of Truvada's active ingredients, tenofovir disoproxil ( TDF ), is a nucleotide analog reverse transcriptase inhibitor.
- Our article on one of Truvada's reverse transcriptase inhibitors ( tenofovir disoproxil says that tenofovir only weakly interferes with DNA polymerases.
- Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate ( TDF ), TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent.
- The first, elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil, is marketed as " Stribild " and was approved by the FDA in August 2012 for use in the United States.
- Tenofovir disoproxil was approved by the U . S . FDA on October 26, 2001, for the treatment of HIV, and on August 11, 2008, for the treatment of chronic hepatitis B.
- Schiano is the currently a Principal Investigator on clinical trial A Rollover Protocol to Provide Open-Label Emtricitabine / Tenofovir Disoproxil Fumarate Combination Product to Subjects Completing the GS-US-203-0107 Study, Protocol GS-US-203-0109.
- The interaction between sofosbuvir and a number of other drugs, such as ciclosporin, darunavir / ritonavir, efavirenz, emtricitabine, methadone, raltegravir, rilpivirine, tacrolimus, or tenofovir disoproxil, were evaluated in clinical trials and no dose adjustment is needed for any of these drugs.
- In a 48-week study comparing elvitegravir / cobicistat / emtricitabine / tenofovir disoproxil ( trade name " Stribild " ) to elvitegravir / cobicistat / emtricitabine / tenofovir alafenamide ( trade name " Genvoya " ), the results showed the newer drug to be noninferior to the established agent, but at much lower dosages and with lower incidence of adverse side effects such as impaired kidney function.
